# Agalsidase Beta (Genetical Recombination) for I.V. Infusion 5mg (ファブラザイム点滴静注用５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3959409D1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3959409D1029
- **Product name (Japanese):** ファブラザイム点滴静注用５ｍｇ
- **English title:** Agalsidase Beta (Genetical Recombination) for I.V. Infusion 5mg
- **Active ingredient:** アガルシダーゼベータ（遺伝子組換え）
- **Active ingredient (INN):** Agalsidase Beta (Genetical Recombination)
- **Strength / unit:** ５ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 395 Enzyme preparations (酵素製剤)
- **Manufacturer:** Sanofi (サノフィ)
- **NHI price (reference only):** JPY 95674 per ５ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3959409D1029
- **JSON:** https://www.nifujipharma.com/api/drugs/3959409D1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Agalsidase%20Beta%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%205mg%20(%E3%83%95%E3%82%A1%E3%83%96%E3%83%A9%E3%82%B6%E3%82%A4%E3%83%A0%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203959409D1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Agalsidase Beta (Genetical Recombination)

- [Agalsidase Beta (Genetical Recombination) for I.V. Infusion 35mg (ファブラザイム点滴静注用３５ｍｇ)](https://www.nifujipharma.com/drugs/3959409D2025) — ３５ｍｇ１瓶, Sanofi